Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy CommunicationsNOW IN
    Article

    Brachychiton acerifolius (A.Cunn. ex G.Don) Macarthur and C. moore Leaf and Flower Extracts Inhibit the Growth of a Panel of Pathogenic Bacteria

    Ian Edwin Cock1,2★★ Corresponding author

    1. 1School of Environment and Science, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2. 2Environmental Futures Research Institute, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

    CORRESPONDENCE

    Ian Edwin Cock

    School of Environment and Science, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

    i.cock@griffith.edu.au

    Volume 10, Issue 1 · pp. 37–43 · PUBLISHED · DOI: 10.5530/pc.2020.1.7

    View on Pharmacogn. Commn. original site ↗

    ABSTRACT

    Introduction: Brachychiton acerifolius (A.Cunn. ex G.Don) Macarthur and C. moore is a large tree that is native to subtropical regions of the east of Australia. Decoctions and infusions produced from the leaves of the related species Brachychiton diversifolius were used by the first Austra¬lians to treat a variety of bacterial diseases. Despite this, B. acerifolius leaf and flower extracts have not been rigorously examined for antibacterial properties against many pathogens. Methods: The antimicrobial activity of B. acerifolius leaf and flower extracts was investigated by disc diffu¬sion and growth time course assays against a panel of pathogenic bacteria. The growth inhibitory activity was quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic B. acerifolius leaf and flower extracts inhibited the growth of a wide range of bacterial species. Growth of both gram positive and gram-negative bacteria was inhibited by the B. acerifolius leaf and flower extracts, although the gram negative bacteria were substantially more susceptible to the extracts than the gram positive bacteria were. The leaf extracts were more potent growth inhibitors than the flower extracts against all bacteria tested. The B. acerifolius leaf extract was a strong inhibitor of A. faecalis, K. pneumonia, P. fluorescens, S. newport, S. sonnei, B. cereus, S. aureus and S. pyogenes growth, with MIC values substantially <1000μg/mL. The antibacterial activity of the methanolic B. acerifolius leaf extract was fur¬ther investigated by growth time course assays which showed significant growth inhibition in cultures of P. fluorsecens and B. cereus within 1hr of exposure. Both extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for internal use as well as for topical uses. Conclusion: The lack of toxicity of the B. acerifolius leaf and flower extracts and their growth inhibitory bioactivity against a panel of pathogenic bacteria partially validate the traditional usage of this species to treat bacterial diseases and indicates their potential in the development of antiseptic agents.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Cock, I. E. (). Brachychiton acerifolius (A.Cunn. ex G.Don) Macarthur and C. moore Leaf and Flower Extracts Inhibit the Growth of a Panel of Pathogenic Bacteria. Pharmacognosy Communications, 10(1), 37–43. https://doi.org/10.5530/pc.2020.1.7